| St Joseph Mercy Hospice, Ann Arbor 3075 Clark Road, Suite 200, Ypsilanti, MI, 48197 | |
| (734) 327-3200 |
News Archive
Agilex Technologies, Inc., a leading provider of mission and technology solutions to the national security, healthcare and public sectors, announced today it was named the region's fastest growing company by the Washington Business Journal. In the company's first year of eligibility, Agilex debuted at the top of the list with reported three year growth of 372.32% and total revenue of $38M (FY2009). This annual ranking covers the entire Washington, DC metro area.
A comparison of three parasite species that cause Leishmaniasis has identified a small number of genes, many new to biology, that will provide a framework to target the search for new treatments.
Diffusion Pharmaceuticals LLC, a biotechnology company focused on innovative cancer treatments, today announced that the U.S. Patent and Trademark Office has granted it patent numbers 7919527 and 8030350, entitled "Bipolar Trans Carotenoids Salts and Their Uses" and "Trans Carotenoids, Their Synthesis and Uses," respectively.
BioMarin Pharmaceutical Inc. announced today that Firdapse™ (3,4-diaminopyridine) is now commercially available in the European Union (E.U.) for the treatment of the rare autoimmune disease Lambert Eaton Myasthenic Syndrome (LEMS). Launching immediately in Germany and the UK, the company expects to subsequently launch Firdapse in all major European markets by the end of 2010.
› Verified 3 days ago
| Name | St Joseph Mercy Hospice, Ann Arbor |
|---|---|
| Location | 3075 Clark Road, Suite 200, Ypsilanti, Michigan |
| Hospice ID | 231511 |
| Category | Freestanding Hospice |
| Ownership Type | Voluntary Non-profit - Other |
| Profit Type | NON-PROFIT |
| Accreditation Provider | Community Health Accreditation Partner (CHAP) |
| SSA county code | 620 |
News Archive
Agilex Technologies, Inc., a leading provider of mission and technology solutions to the national security, healthcare and public sectors, announced today it was named the region's fastest growing company by the Washington Business Journal. In the company's first year of eligibility, Agilex debuted at the top of the list with reported three year growth of 372.32% and total revenue of $38M (FY2009). This annual ranking covers the entire Washington, DC metro area.
A comparison of three parasite species that cause Leishmaniasis has identified a small number of genes, many new to biology, that will provide a framework to target the search for new treatments.
Diffusion Pharmaceuticals LLC, a biotechnology company focused on innovative cancer treatments, today announced that the U.S. Patent and Trademark Office has granted it patent numbers 7919527 and 8030350, entitled "Bipolar Trans Carotenoids Salts and Their Uses" and "Trans Carotenoids, Their Synthesis and Uses," respectively.
BioMarin Pharmaceutical Inc. announced today that Firdapse™ (3,4-diaminopyridine) is now commercially available in the European Union (E.U.) for the treatment of the rare autoimmune disease Lambert Eaton Myasthenic Syndrome (LEMS). Launching immediately in Germany and the UK, the company expects to subsequently launch Firdapse in all major European markets by the end of 2010.
› Verified 3 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 99.4 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 94.2 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 97.9 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 85.9 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 99.7 | 97.3 |
| Patients who got timely treatment for shortness of breath | 94.4 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 100.0 | 93.3 |
News Archive
Agilex Technologies, Inc., a leading provider of mission and technology solutions to the national security, healthcare and public sectors, announced today it was named the region's fastest growing company by the Washington Business Journal. In the company's first year of eligibility, Agilex debuted at the top of the list with reported three year growth of 372.32% and total revenue of $38M (FY2009). This annual ranking covers the entire Washington, DC metro area.
A comparison of three parasite species that cause Leishmaniasis has identified a small number of genes, many new to biology, that will provide a framework to target the search for new treatments.
Diffusion Pharmaceuticals LLC, a biotechnology company focused on innovative cancer treatments, today announced that the U.S. Patent and Trademark Office has granted it patent numbers 7919527 and 8030350, entitled "Bipolar Trans Carotenoids Salts and Their Uses" and "Trans Carotenoids, Their Synthesis and Uses," respectively.
BioMarin Pharmaceutical Inc. announced today that Firdapse™ (3,4-diaminopyridine) is now commercially available in the European Union (E.U.) for the treatment of the rare autoimmune disease Lambert Eaton Myasthenic Syndrome (LEMS). Launching immediately in Germany and the UK, the company expects to subsequently launch Firdapse in all major European markets by the end of 2010.
› Verified 3 days ago
| Home Health Aides | 4.5 |
| Counselors | 2.5 |
| Licensed Practical or Vocational Nurses | 1 |
| Medical Social Workers | 3 |
| Registered Nurses | 7.5 |
| Other Personnel | 8 |
| Total Employees | 26.5 |
|---|
News Archive
Agilex Technologies, Inc., a leading provider of mission and technology solutions to the national security, healthcare and public sectors, announced today it was named the region's fastest growing company by the Washington Business Journal. In the company's first year of eligibility, Agilex debuted at the top of the list with reported three year growth of 372.32% and total revenue of $38M (FY2009). This annual ranking covers the entire Washington, DC metro area.
A comparison of three parasite species that cause Leishmaniasis has identified a small number of genes, many new to biology, that will provide a framework to target the search for new treatments.
Diffusion Pharmaceuticals LLC, a biotechnology company focused on innovative cancer treatments, today announced that the U.S. Patent and Trademark Office has granted it patent numbers 7919527 and 8030350, entitled "Bipolar Trans Carotenoids Salts and Their Uses" and "Trans Carotenoids, Their Synthesis and Uses," respectively.
BioMarin Pharmaceutical Inc. announced today that Firdapse™ (3,4-diaminopyridine) is now commercially available in the European Union (E.U.) for the treatment of the rare autoimmune disease Lambert Eaton Myasthenic Syndrome (LEMS). Launching immediately in Germany and the UK, the company expects to subsequently launch Firdapse in all major European markets by the end of 2010.
› Verified 3 days ago
| St Joseph Mercy Hospice, Ann Arbor Location: 3075 Clark Road, Suite 200, Ypsilanti, Michigan, 48197 Phone: (734) 327-3200 |